Metolazone Production Cost Reports

Metolazone production cost report provides a comprehensive analysis and know-how for setting up a Metolazone production plant. The study covers all the requisite aspects that one needs to know for the production of Metolazone. This includes manufacturing processes, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.

Metolazone is a pharmaceutical medication with a complex chemical formula of C16H16ClN3O3S, and its molecular weight is 365.8 g/mol. It is a quinazoline comprising of 1,2,3,4-tetrahydroquinazolin-4-one attached with a methyl, 2-tolyl, sulfamoyl, and chloro group at its 2nd, 3rd, 6th, and 7th positions, respectively. It is a crystalline solid and has no odor or taste. Its melting point is measured at approximately 256°C.

It is moderately soluble in water and can be dissolved in different chemical solvents, including alcohols, such as ethanol. Similarly, it is soluble in dimethyl sulfoxide or DMSO and dimethyl formamide, also known as DMF. The compound is also sparingly soluble in aqueous buffer solutions. It is a light-sensitive chemical solid that can remain stable under standard conditions. However, it decomposes when heated at an elevated temperature and releases irritating fumes, nitrogen oxide, hydrogen chloride, and carbon monoxide into the air.

Metolazone is primarily associated with the pharmaceutical and healthcare sectors. The compound belongs to the class of thiazide diuretic drugs and is majorly used to develop tablets and pills for curing heart and kidney conditions.  It serves as a major ingredient, a diuretic drug, and is taken in the form of pills to treat high blood pressure.

It helps in treating fluid retention, caused by congestive heart failure or kidney conditions. Moreover, its combination with other medicines can be used to treat conditions of hypertension and related complications. It reduces the risk of heart failure due to high blood pressure and, hence, ensures the functioning of a healthy heart.

The market for Metolazone is driven by its wide-scale demand in the pharmaceutical and healthcare sectors. Its utilization in the preparation of diuretic drugs that are taken to treat heart and kidney conditions boosts its demand in the pharmaceutical industry. Moreover, its effectiveness with a combination of other pharmaceutical medications to treat hypertension amplifies its demand in the healthcare sector. The procurement of Metolazone is largely dependent upon its demand in the market. Hence, the variations in its demand as a diuretic drug in the healthcare and pharmaceutical domain are essential for its global procurement.